D.E. Shaw & Co’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-87,990
Closed -$4.7M 3758
2016
Q1
$4.7M Sell
87,990
-70,780
-45% -$5.22M 0.01% 1321
2015
Q4
$17.9M Buy
158,770
+2,748
+2% +$303K 0.03% 684
2015
Q3
$18.4M Sell
156,022
-19,944
-11% -$2.6M 0.03% 658
2015
Q2
$13.6M Buy
175,966
+77,591
+79% +$5.09M 0.02% 833
2015
Q1
$5.69M Buy
98,375
+54,506
+124% +$2.31M 0.01% 1296
2014
Q4
$1.42M Buy
43,869
+617
+1% +$18.5K ﹤0.01% 2559
2014
Q3
$1.06M Buy
43,252
+23,078
+114% +$469K ﹤0.01% 2757
2014
Q2
$358K Buy
20,174
+5,641
+39% +$90.8K ﹤0.01% 3749
2014
Q1
$291K Sell
14,533
-37,281
-72% -$723K ﹤0.01% 3925
2013
Q4
$869K Buy
51,814
+1,328
+3% +$18.4K ﹤0.01% 3301
2013
Q3
$536K Buy
+50,486
New +$442K ﹤0.01% 3534

Other funds holding ANAC

D.E. Shaw & Co's ANAC Position: Q2 2016 in Review

D.E. Shaw & Co sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 87,990 shares — an estimated $4.7M sold.

D.E. Shaw & Co first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $18.4M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • D.E. Shaw & Co reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 87,990 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $4.7M.
  • D.E. Shaw & Co first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • D.E. Shaw & Co's ANACOR PHARMACEUTICALS INC COM position peaked at $18.4M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.